(Q45071766)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20827284%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

title

Effects of fluvastatin on insulin resistance and cardiac morphology in hypertensive patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20827284%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20827284%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

author name string

A A Teixeira

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20827284%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

A Buffani

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20827284%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

A Tavares

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20827284%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

A B Ribeiro

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20827284%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

O Kohlmann

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20827284%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

M C Batista

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20827284%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

publication date

9 September 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20827284%20AND%20SRC:MED&resulttype=core&format=json

Journal of Human Hypertension

13 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20827284%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20827284%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20827284%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

page(s)

492-499

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20827284%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/jhh.2010.87

13 February 2020

exact match

0 references

cites work

Serum cholesterol level and mortality findings for men screened in the Multiple Risk Factor Intervention Trial. Multiple Risk Factor Intervention Trial Research Group

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.87

Risk factors for a major coronary event after myocardial infarction in the Scandinavian Simvastatin Survival Study (4S). Impact of predicted risk on the benefit of cholesterol-lowering treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.87

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.87

Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.87

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.87

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.87

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.87

Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.87

Improvement of left ventricular remodeling and function by hydroxymethylglutaryl coenzyme a reductase inhibition with cerivastatin in rats with heart failure after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.87

Effects of pravastatin on progression of glucose intolerance and cardiovascular remodeling in a type II diabetes model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.87

Amelioration of angiotensin II-induced cardiac injury by a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.87

Pravastatin attenuates left ventricular remodeling and diastolic dysfunction in angiotensin II-induced hypertensive mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.87

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.87

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.87

Effects of atorvastatin on aortic pulse wave velocity in patients with hypertension and hypercholesterolaemia: a preliminary study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.87

HMG-CoA reductase inhibitors improve endothelial dysfunction in normocholesterolemic hypertension via reduced production of reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.87

Insulin sensitivity and insulin secretion determined by homeostasis model assessment and risk of diabetes in a multiethnic cohort of women: the Women's Health Initiative Observational Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.87

Fluvastatin improves insulin resistance in nondiabetic dyslipidemic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.87

Effects of a statin group drug, pravastatin, on the insulin resistance in patients with metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.87

Pravastatin and the development of diabetes mellitus: evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.87

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.87

Atorvastatin causes insulin resistance and increases ambient glycemia in hypercholesterolemic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.87

3-HMG-Coenzyme A reductase inhibition and extracellular matrix gene expression in the pressure-overloaded rat heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.87

Effects of simvastatin on blood lipids, vitamin E, coenzyme Q10 levels and left ventricular function in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.87

Do Statins Reduce Blood Pressure?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.87

Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.87

7 January 2021

Reduction of albumin excretion rate in normotensive microalbuminuric type 2 diabetic patients during long-term simvastatin treatment

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.87

7 January 2021

Short term effects of pravastatin on blood pressure in hypercholesterolaemic hypertensive patients

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.87

7 January 2021

Additional reduction in blood pressure after cholesterol-lowering treatment by statins (lovastatin or pravastatin) in hypercholesterolemic patients using angiotensin-converting enzyme inhibitors (enalapril or lisinopril)

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.87

7 January 2021

Effect of the HMG-CoA reductase inhibitors on blood pressure in patients with essential hypertension and primary hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.87

7 January 2021

Rosuvastatin improves basal nitric oxide activity of the renal vasculature in patients with hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.87

7 January 2021

Effects of lipid-lowering drugs on left ventricular function and exercise tolerance in dyslipidemic coronary patients

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2010.87

7 January 2021

Identifiers

DOI

10.1038/JHH.2010.87

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20827284%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

13 February 2020

1051518562

0 references

1 reference